Everything Genetic: Bringing the Resourcefulness of Genetic Testing to Everyone
Simon Davis, Commercial Director
In a harmonious combination with advanced technologies, the world of medicine has pushed the limits of what we understand to be the extent of biological possibilities. Notably, the innovation of genetic testing is highly commendable. With a patient’s saliva sample alone, clinicians can obtain vital information that can help identify specific gene mutations associated with various diseases, allowing for pre-emptive action. It is clear that genetic testing can help direct people toward getting the best treatments and, conversely, a better quality of life with fewer health concerns, especially for those with a history of family illness. However, if individuals stand to gain so much from such a non-intrusive process, why is genetic testing not a mainstream avenue today? The answer has many layers, but the top few revolve around cost, speed, and accessibility of the necessary resources. Certain government authorities and publicly funded healthcare systems like the National Health Service (NHS) do offer free genetic testing, but only if it is referred to by a hospital specialist based on suspicion of genetic disorders or cancer.
This healthcare structure simply is not viable, as many people are still unable to afford the tests they need. Everything Genetic, a distributor of market-leading genetic test brands in the UK, also believes the same and thus collaborates with various laboratories to develop and supply affordable testing solutions to health systems throughout the nation. “Our mission is to democratise genetic testing,” states Simon Davis, sales and marketing director at Everything Genetic.
The company’s tests and services empower people to avail cost-effective genetic tests with the added benefits of clinical support and counselling. The company maintains a massive portfolio of offerings, including molecular tests for different areas of a patient’s clinical pathway, predominantly focusing on hereditary cancer. “Immediate access to a genetic answer pertaining to a patient’s condition drives a therapeutic or surgical choice. I think, for a patient, this is massive. It can mean eliminating the delay in a course of action for their cancer,” explains Davis. Everything Genetic works very closely with clinicians and hospital groups to help alleviate as many administrative burdens as possible and create a more streamlined, accessible pathway for those seeking genetic test results.
James Price, CEO
The company offers a wide variety of services and test kits that help a patient examine their risks of cancer and heart disease, all the while analysing the genes that can influence how their bodies process different kinds of medication.
Our mission is to democratize genetic testing
Owing to its diversified network in the healthcare industry, Everything Genetic works with NHS and private medical insurers like Bupa UK to further simplify the entire genetic testing process, allowing clinicians and other practitioners to deliver the best patient care possible. Additionally, the company maintains a highly secure and automated online portal—with two-step authentication—that houses important clinical data sets about patients, thereby helping all those in the pathway to obtain all the information they would need. “We have evolved rapidly over the last few years by adding several new services to our portfolio for both private and national health services,” says Davis. One of Everything Genetic’s noteworthy milestones is the launch of Prosigna, a NICE approved genomic assay for assessing risk of recurrence in early breast cancer patients. Backed by significant clinical evidence, the company’s tests have proved to be more accurate with faster turnaround times than most other tests in the market today.
With such incredible services being delivered to those seeking medical aid, Everything Genetic stands as a beacon of new hope in the realm of preventative medicine. The firm is built on the ethos of bringing access to testing to more patients that need it and delivering superior service, and it effectively delivers on that vision. Following request from their partners the company is also supporting cancer patients in the fight against COVID-19 with its comprehensive PCR tests pre chemotherapy to ensure safe to start treatment., having completed over 200,000 tests in the last six months. Moving forward, Everything Genetic is gearing up to conduct over 25,000 PCR tests in a single day, all the while cherry-picking the best genetic testing solutions for the betterment of patient care delivery in the UK.